Active 0 6 0 6 O
GI 7 9 7 9 B-chronic_disease
hemorrhage 10 20 10 20 I-chronic_disease
within 21 27 21 27 O
2 28 29 28 29 B-upper_bound
weeks 30 35 30 35 I-upper_bound
of 36 38 36 38 O
study 39 44 39 44 O
enrollment 45 55 45 55 O

Age 0 3 56 59 B-age
18 4 6 60 62 B-upper_bound
years 7 12 63 68 I-upper_bound
old 13 16 69 72 O

Albumin 0 7 73 80 B-clinical_variable
2.4 8 11 81 84 O
g 12 13 85 86 O
/ 13 14 86 87 O
dL 14 16 87 89 O
; 16 17 89 90 O
Total 18 23 91 96 O
bilirubin 24 33 97 106 B-clinical_variable
2 34 35 107 108 O
mg 36 38 109 111 O
/ 38 39 111 112 O
dL 39 41 112 114 O
; 41 42 114 115 O
INR 43 46 116 119 B-clinical_variable
1.5 47 50 120 123 O

Ascites 0 7 124 131 B-chronic_disease
refractory 8 18 132 142 I-chronic_disease
to 19 21 143 145 O
medical 22 29 146 153 B-treatment
therapy 30 37 154 161 I-treatment

Child 0 5 162 167 B-clinical_variable
- 5 6 167 168 I-clinical_variable
Turcotte 6 14 168 176 I-clinical_variable
- 14 15 176 177 I-clinical_variable
Pugh 15 19 177 181 I-clinical_variable
Classification 20 34 182 196 I-clinical_variable
A 35 36 197 198 B-lower_bound
or 37 39 199 201 O
B 40 41 202 203 B-upper_bound

Contraindication 0 16 204 220 O
to 17 19 221 223 O
contrast 20 28 224 232 O
enhanced 29 37 233 241 O
MRI 38 41 242 245 B-treatment
( 42 43 246 247 O
i.e. 43 47 247 251 O
unable 48 54 252 258 O
to 55 57 259 261 O
undergo 58 65 262 269 O
follow 66 72 270 276 O
- 72 73 276 277 O
up 73 75 277 279 O
imaging 76 83 280 287 O
) 83 84 287 288 O

Contraindication 0 16 289 305 O
to 17 19 306 308 O
receiving 20 29 309 318 O
HCQ 30 33 319 322 B-treatment
or 34 36 323 325 O
TACE 37 41 326 330 B-treatment

Creatinine 0 10 331 341 B-clinical_variable
2.0 11 14 342 345 O
mg 15 17 346 348 O
/ 17 18 348 349 O
dL 18 20 349 351 O
, 20 21 351 352 O
AST 22 25 353 356 B-clinical_variable
121 26 29 357 360 O
IU 30 32 361 363 O
/ 32 33 363 364 O
L 33 34 364 365 O
; 34 35 365 366 O
ALT 36 39 367 370 B-clinical_variable
189 40 43 371 374 O
IU 44 46 375 377 O
/ 46 47 377 378 O
L 47 48 378 379 O

Eastern 0 7 380 387 B-clinical_variable
Clinical 8 16 388 396 I-clinical_variable
Oncology 17 25 397 405 I-clinical_variable
Group 26 31 406 411 I-clinical_variable
performance 32 43 412 423 I-clinical_variable
status 44 50 424 430 I-clinical_variable
0 51 52 431 432 B-lower_bound
or1 53 56 433 436 O

Participation 0 13 437 450 O
in 14 16 451 453 O
another 17 24 454 461 O
concurrent 25 35 462 472 O
treatment 36 45 473 482 B-treatment
protocol 46 54 483 491 O

Patient 0 7 492 499 O
diagnosed 8 17 500 509 O
with 18 22 510 514 O
hepatocellular 23 37 515 529 B-cancer
carcinoma 38 47 530 539 I-cancer
in 48 50 540 542 O
both 51 55 543 547 O
lobes 56 61 548 553 O
of 62 64 554 556 O
the 65 68 557 560 O
liver 69 74 561 566 O
by 75 77 567 569 O
one 78 81 570 573 O
of 82 84 574 576 O
the 85 88 577 580 O
following 89 98 581 590 O
methods 99 106 591 598 O
( 107 108 599 600 O
Pathologically 108 122 600 614 O
confirmed 123 132 615 624 O
HCC 133 136 625 628 B-cancer
by 137 139 629 631 O
biopsy 140 146 632 638 B-treatment
or 147 149 639 641 O
HCC 150 153 642 645 O
2 154 155 646 647 B-lower_bound
cm 156 158 648 650 I-lower_bound
with 159 163 651 655 O
classic 164 171 656 663 O
radiographic 172 184 664 676 O
findings 185 193 677 685 O
of 194 196 686 688 O
arterial 197 205 689 697 O
phase 206 211 698 703 O
enhancement 212 223 704 715 O
with 224 228 716 720 O
venous 229 235 721 727 O
phase 236 241 728 733 O
washout 242 249 734 741 O
and 250 253 742 745 O
pseudocapsule 254 267 746 759 O
formation 268 277 760 769 O
on 278 280 770 772 O
contrast 281 289 773 781 O
enhanced 290 298 782 790 O
MRI 299 302 791 794 B-treatment
or 303 305 795 797 O
CT 306 308 798 800 B-treatment
or 309 311 801 803 O
Lesion 312 318 804 810 B-clinical_variable
greater 319 326 811 818 O
than 327 331 819 823 O
2 332 333 824 825 O
cm 334 336 826 828 O
with 337 341 829 833 O
probable 342 350 834 842 O
imaging 351 358 843 850 O
features 359 367 851 859 O
of 368 370 860 862 O
HCC 371 374 863 866 O
and 375 378 867 870 O
imaging 379 386 871 878 O
findings 387 395 879 887 O
of 396 398 888 890 O
cirrhosis 399 408 891 900 B-chronic_disease
and/or 409 415 901 907 O
portal 416 422 908 914 B-chronic_disease
hypertension 423 435 915 927 I-chronic_disease
or 436 438 928 930 O
a 439 440 931 932 O
serum 441 446 933 938 B-clinical_variable
alphafetoprotein 447 463 939 955 I-clinical_variable
( 464 465 956 957 I-clinical_variable
AFP 465 468 957 960 I-clinical_variable
) 468 469 960 961 I-clinical_variable
greater 470 477 962 969 O
than 478 482 970 974 O
200 483 486 975 978 B-lower_bound
mg 487 489 979 981 I-lower_bound
/ 489 490 981 982 I-lower_bound
mL 490 492 982 984 I-lower_bound

Patient 0 7 985 992 O
not 8 11 993 996 O
candidate 12 21 997 1006 O
for 22 25 1007 1010 O
orthotopic 26 36 1011 1021 B-treatment
liver 37 42 1022 1027 I-treatment
transplantation 43 58 1028 1043 I-treatment
at 59 61 1044 1046 O
the 62 65 1047 1050 O
Hospital 66 74 1051 1059 O
of 75 77 1060 1062 O
the 78 81 1063 1066 O
University 82 92 1067 1077 O
of 93 95 1078 1080 O
Pennsylvania 96 108 1081 1093 O
based 109 114 1094 1099 O
on 115 117 1100 1102 O
review 118 124 1103 1109 O
of 125 127 1110 1112 O
patient 128 135 1113 1120 O
imaging 136 143 1121 1128 O
and 144 147 1129 1132 O
history 148 155 1133 1140 O
at 156 158 1141 1143 O
multidisciplinary 159 176 1144 1161 O
Hepatic 177 184 1162 1169 O
Tumor 185 190 1170 1175 O
Conference 191 201 1176 1186 O
at 202 204 1187 1189 O
the 205 208 1190 1193 O
Hospital 209 217 1194 1202 O
of 218 220 1203 1205 O
the 221 224 1206 1209 O
University 225 235 1210 1220 O
of 236 238 1221 1223 O
Pennsylvania 239 251 1224 1236 O

Prior 0 5 1237 1242 B-treatment
TACE 6 10 1243 1247 I-treatment

Unilobar 0 8 1248 1256 O
HCC 9 12 1257 1260 B-cancer

Women 0 5 1261 1266 B-gender
who 6 9 1267 1270 O
are 10 13 1271 1274 B-pregnancy
pregnant 14 22 1275 1283 I-pregnancy

